
403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Yeast Extract Market Size To Reach $1, .3 Million, By 2035 At 7.5% CAGR
EINPresswire/ -- Yeast extract is anticipated to become more widely used in a variety of food and beverage applications due to consumer preferences for natural and clean-label products
Request Sample Pages:
Prime determinants of growth
The growing demand for clean-label food products and natural flavor enhancers is propelling the yeast extract industry. Consumers' growing health consciousness has increased interest in using yeast extract as an alternative to artificial additives because of its rich umami flavor and nutritional advantages, such as its high protein and vitamin content. Veganism and plant-based diets are becoming more and more popular, which encourages their use in a variety of culinary applications. Yeast extract's commercial potential is further increased by its substantial application in the cosmetics and medicinal sectors. However, obstacles including shifting raw material costs and competition from substitute taste enhancers could impede expansion. Profitable prospects for market participants are presented by advancements in extraction methods and growing uses in prepared foods.
Buy this Complete Report (250 Pages PDF with Insights, Charts, Tables, and Figures) at:
The active dry yeast segment to maintain its leadership status during the forecast period
By type, the active dry yeast segment held the highest market share in 2023, accounting for more than half of the yeast extract market share and is estimated to maintain its leadership status during the forecast period. The yeast extracts market uses active dry yeast owing to its excellent quality, stability, and capacity to improve fermentation processes.
The pharmaceutical segment to maintain its leadership status during the forecast period
By application, the pharmaceutical segment held the highest market share in 2023, accounting for more than four-fifths of the yeast extract market revenue and is estimated to maintain its leadership status during the forecast period. Yeast extract is essential to the pharmaceutical industry's production of therapeutic proteins, vaccines, and biologics.
The dry segment to maintain its leadership status during the forecast period
By form, the dry segment held the highest market share in 2023, accounting for more than three-fifths of the yeast extract market revenue and is estimated to maintain its leadership status during the forecast period. The dry form of yeast extract is frequently utilized in biotechnology and pharmaceutical industries owing to its ease of storage, stability, and convenience.
Europe to maintain its dominance by 2035
Based on region, Europe held the highest market share in terms of revenue in 2023 and is expected to dominate the market during the forecast period. The production of monoclonal antibodies, vaccines, and therapeutic proteins using yeast extract is common in Europe and helps meet the rising demand for biologics.
Enquiry Before Buying:
Leading Market Players: -
AngelYeast Co., Ltd.
Associated British Foods PLC
CELLSECO LTD.
FUJIFILM Irvine Scientific
Kerry Group
Lallemand Inc.
LESAFFRE GROUP
Merck KGaA
Nu-Tek BioSciences
Thermo Fisher Scientific Inc.
VWR International, LLC
The report provides a detailed analysis of these key players in the yeast extract market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Request Sample Pages:
Prime determinants of growth
The growing demand for clean-label food products and natural flavor enhancers is propelling the yeast extract industry. Consumers' growing health consciousness has increased interest in using yeast extract as an alternative to artificial additives because of its rich umami flavor and nutritional advantages, such as its high protein and vitamin content. Veganism and plant-based diets are becoming more and more popular, which encourages their use in a variety of culinary applications. Yeast extract's commercial potential is further increased by its substantial application in the cosmetics and medicinal sectors. However, obstacles including shifting raw material costs and competition from substitute taste enhancers could impede expansion. Profitable prospects for market participants are presented by advancements in extraction methods and growing uses in prepared foods.
Buy this Complete Report (250 Pages PDF with Insights, Charts, Tables, and Figures) at:
The active dry yeast segment to maintain its leadership status during the forecast period
By type, the active dry yeast segment held the highest market share in 2023, accounting for more than half of the yeast extract market share and is estimated to maintain its leadership status during the forecast period. The yeast extracts market uses active dry yeast owing to its excellent quality, stability, and capacity to improve fermentation processes.
The pharmaceutical segment to maintain its leadership status during the forecast period
By application, the pharmaceutical segment held the highest market share in 2023, accounting for more than four-fifths of the yeast extract market revenue and is estimated to maintain its leadership status during the forecast period. Yeast extract is essential to the pharmaceutical industry's production of therapeutic proteins, vaccines, and biologics.
The dry segment to maintain its leadership status during the forecast period
By form, the dry segment held the highest market share in 2023, accounting for more than three-fifths of the yeast extract market revenue and is estimated to maintain its leadership status during the forecast period. The dry form of yeast extract is frequently utilized in biotechnology and pharmaceutical industries owing to its ease of storage, stability, and convenience.
Europe to maintain its dominance by 2035
Based on region, Europe held the highest market share in terms of revenue in 2023 and is expected to dominate the market during the forecast period. The production of monoclonal antibodies, vaccines, and therapeutic proteins using yeast extract is common in Europe and helps meet the rising demand for biologics.
Enquiry Before Buying:
Leading Market Players: -
AngelYeast Co., Ltd.
Associated British Foods PLC
CELLSECO LTD.
FUJIFILM Irvine Scientific
Kerry Group
Lallemand Inc.
LESAFFRE GROUP
Merck KGaA
Nu-Tek BioSciences
Thermo Fisher Scientific Inc.
VWR International, LLC
The report provides a detailed analysis of these key players in the yeast extract market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Pepeto Presale Exceeds $6.93 Million Staking And Exchange Demo Released
- Citadel Launches Suiball, The First Sui-Native Hardware Wallet
- Luminadata Unveils GAAP & SOX-Trained AI Agents Achieving 99.8% Reconciliation Accuracy
- Tradesta Becomes The First Perpetuals Exchange To Launch Equities On Avalanche
- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
Comments
No comment